Exploring the long-term complications of COVID-19 and its prevention through comparison with SARS and MERS

Abstract

Abstract: The pandemic of COVID-19 in China has made the pathogen SARS-CoV-2 become a hot spot. SARS-CoV and MERS-CoV are classified into beta-coronavirus genus and mainly attack respiratory system. This article explores the long-term prognosis of patients with COVID-19 through comparison of patients with SARS and MERS in order to explore potential prevention strategy as well as method.

Key words: COVID-19, long-term prognosis, lung function, liver and kidney function impairment, quality of life

CLC Number:

R563

HU Jing-jing, TONG Jin. Exploring the long-term complications of COVID-19 and its prevention through comparison with SARS and MERS[J]. Basic & Clinical Medicine, 2020, 40(7): 887-892.

References

[1] Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China[J]. N Engl J Med, 2020, 382: 727-733.
[2] Hui DS, I Azhar E, Madani T, et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health; The latest 2019 novel coronavirus outbreak in Wuhan, China[J]. Int J Infect Dis, 2020, 91: 264-266.
[3] Lu R, Zhao X, Liu J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding[J]. Lancet, 2020, 395: 565-574.
[4] Letko M, Marzi A, Munster V. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses[J]. Nat Microbiol, 2020, 5: 562-569.
[5] Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Preven-tion[J/OL]. JAMA, 2020. doi: 10.1001/jama.2020.2648.
[6] Cleri DJ, Ricketti AJ, Vernaleo JR. Severe acute respiratory syndrome (SARS)[J]. Infect Dis Clin North Am, 2010, 24: 175-202.
[7] Nassar MS, Bakhrebah MA, Meo SA, et al. Middle east respiratory syndrome coronavirus (MERS-CoV) infection: epidemiology, pathogenesis and clinical characteristics[J]. Eur Rev Med Pharmacol Sci, 2018, 22: 4956-4961.
[8] Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of 2019 novel coronavirus infection in China[J]. N Engl J Med, 2020, 382: 1708-1720.
[9] 刘茜,王荣帅,屈国强,等. 新型冠状病毒肺炎死亡尸体系统解剖大体观察报告[J]. 法医学杂志, 2020, 36: 19-21.
[10] Hui DS, Joynt GM, Wong KT, et al. Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors[J]. Thorax, 2005, 60: 401-409.
[11] 严梅,危天倪,彭堃,等. 严重急性呼吸综合征康复期患者肺功能五年动态观察[J]. 中国全科医学, 2010, 13: 1068-1069, 1072.
[12] Chung M, Bernheim A, Mei X, et al. CT imaging features of 2019 novel coronavirus (2019-nCoV)[J]. Radiology, 2020, 295: 202-207.
[13] 张伟宏,金征宇,王沄,等. SARS患者出院后恢复期的CT表现与肺功能相关性研究[J]. 中华放射学杂志, 2004, 38: 477-481.
[14] Ong KC, Ng AW, Lee LS, et al. Pulmonary function and exercise capacity in survivors of severe acute respiratory syndrome[J]. Eur Respir J, 2004, 24: 436-442.
[15] Ngai JC, Ko FW, Ng SS, et al. The long-term impact of severe acute respiratory syndrome on pulmonary function, exercise capacity and health status[J]. Respirology, 2010, 15: 543-550.
[16] 2019新型冠状病毒肺炎呼吸康复指导意见(第二版)[J]. 中华结核和呼吸杂志, 2020, 42: 308-314.
[17] Wu X, Dong D, Ma D. Thin-section computed tomo-graphy manifestations during convalescence and long-term fllow-up of patients with severe acute respiratory syndrome (SARS)[J]. Med Sci Monit, 2016, 22: 2793-2799.
[18] 彭堃, 庞宝森, 危天倪, 等. 严重急性呼吸综合征的临床特点及遗留肺纤维化相关因素分析[J]. 首都医科大学学报, 2006, 41: 43-47.
[19] Das KM, Lee EY, Singh R, et al. Follow-up chest radiographic findings in patients with MERS-CoV after recovery[J]. Indian J Radiol Imaging, 2017, 27: 342-349.
[20] 王丽. 急性呼吸窘迫综合征早期肺纤维化的研究进展[J]. 国外医学: 呼吸系统分册, 2003, 23: 50-54.
[21] Armstrong L, Thickett DR, Mansell JP, et al. Changes in collagen turnover in early acute respiratory distress syndrome[J]. Am J Respir Crit Care Med, 1999, 160: 1910-1915.
[22] 孔琪, 秦川. 肺纤维化的发病机制及关键靶点[J]. 国外医学: 呼吸系统分册, 2005, 25: 331-333, 336.
[23] Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China[J]. Lancet, 2020, 395: 497-506.
[24] Dowman L, Hill CJ, Holland AE. Pulmonary rehabilita-tion for interstitial lung disease[J/OL]. Cochrane Database Syst Rev, 2014. doi: 10.1016/S0140-6736(20)30183-5.
[25] Sköld CM, Bendstrup E, Myllärniemi M, et al. Treatment of idiopathic pulmonary fibrosis: a position paper from a Nordic expert group[J]. J Intern Med, 2017, 281: 149-166.
[26] 曹武奎, 焦振山, 曹茜, 等. SARS患者生化指标的动态变化及其意义[J]. 天津医药, 2006, 34: 48-50.
[27] 马龙艳, 孙昕, 吴琦, 等. 天津地区SARS患者康复十年后实验室检查指标分析[J]. 天津医药, 2016, 44: 1102-1104.
[28] Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study[J]. Lancet, 2020, 395: 507-513.
[29] Fan Z, Chen L, Li J, et al. Clinical features of COVID-19 related liver damage[J/OL]. Clin Gastroenterol Hepatol, 2020. doi: 10.1016/j.cgh.2020.04.002.
[30] Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China[J/OL]. JAMA, 2020.doi: 10.1001/jama.2020.1585.
[31] Gupta KK, Khan MA, Singh SK. Constitutive inflamma-tory cytokine storm: a major threat to human health[J]. J Interferon Cytokine Res, 2020, 40: 19-23.
[32] Núñez M. Clinical syndromes and consequences of antiretroviral-related hepatotoxicity[J]. Hepatology, 2010, 52: 1143-1155.
[33] 李晓骄阳, 李雅静, 葛俊德, 等. 注重新型冠状病毒肺炎(COVID-19)治疗中药物性肝损伤的预警与保护[J]. 中草药, 2020, 51: 1-9.
[34] 范立. 严重急性呼吸综合征患者尿常规及血清尿素氮、肌酐检验结果的分析[J]. 中国医药指南, 2015, 13: 45-46.
[35] Li Z, Wu M, Yao JW, et al. Caution on kidney dysfunctions of 2019-nCoV patients[J/OL]. medRxiv, 2020. doi: org/10.1101/2020.02.08.20021212.
[36] Caibin F, Kai L, Ding YH, et al. ACE2 expression in kidney and testis may cause kidney and testis damage after 2019-nCoV infection[J/OL]. medRxiv, 2020.doi: org/10.1101/2020.02.12.20022418.
[37] 华静娜, 孙昕, 吴琦, 等. 严重急性呼吸综合征患者十年生存质量分析[J]. 天津医药, 2016, 44: 1247-1251.
[38] Batawi S, Tarazan N, Al-Raddadi R, et al. Quality of life reported by survivors after hospitalization for middle east respiratory syndrome (MERS)[J]. Health Qual Life Outcomes, 2019, 17: 101. doi: 10.1186/s12955-019-1165-2.
[39] Chua SE, Cheung V, McAlonan GM, et al. Stress and psychological impact on SARS patients during the outbreak. [J]. Can J Psychiatry, 2004, 49: 385-390.
[40] Mak IW, Chu CM, Pan PC, et al. Long-term psychiatric morbidities among SARS survivors[J]. Gen Hosp Psychiatry, 2009, 31: 318-326.
[41] 石川, 于欣, 洪楠, 等. 医务人员严重急性呼吸综合征幸存者康复期情绪、记忆和日常生活功能[J]. 中国心理卫生杂志, 2011, 25: 660-665.
[42] Hatch R, Young D, Barber V, et al. Anxiety, depression and post traumatic stress disorder after critical illness: a UK-wide prospective cohort study[J]. Crit Care, 2018, 22: 310. doi: 10.1186/s13054-018-2223-6.